Antimicrobial resistance (AMR) is the global health crisis of our time. Canadians depend on effective antibiotics for their health and safety. Because of AMR, the miracles of safe childbirth, artificial joints, routine surgery, transplantation, and cancer therapy are all at risk. Antimicrobials play parallel roles in animal health, being important for the health and welfare of companion and farm animals, and facilitating humane, safe and economically viable food production, to help assure food security for Canadians and maintain and develop export markets.
Our vision is to prevent the wholesale disruption of our health care system from unchecked AMR and preserve the miracle of antimicrobial therapy for future generations of Canadians.
In 2017, the Public Health Agency of Canada released "Tackling Antimicrobial Resistance and Use: a Pan-Canadian Framework for Action". A key component of that involves strengthening Canada’s ability to combat the risks of AMR in a coordinated, multisectoral and effective manner. CANresist was developed in response to this action plan, to help coordinate activities in this diverse field.
CANresist is a multidisciplinary network coordinated by Dr. Andrew M Morris MD SM (Professor of Medicine at the University of Toronto, and Director of the Sinai Health System-University Health Network AS Program), Dr. David M Patrick MD MHSc (Professor and Director of the School of Population & Public Health at the University of British Columbia) and Dr. J Scott Weese DVM DVSc DACVIM (Canada Research Chair in Zoonotic Diseases, Professor at the University of Guelph and Chief of Infection Control at the Ontario Veterinary College Health Sciences Centre), along with Network Director Yoshiko Nakamachi.
More information on CANresist partners and collaborators coming soon.